Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

VentriPoint Diagnostics Ltd V.VPT

Alternate Symbol(s):  VPTDF

Healthcare Medical Devices
Ventripoint Diagnostics Ltd. is a Canada-based medical device company. It is engaged in the development and commercialization of diagnostic tools to monitor patients with heart disease. It develops a suite of applications for all heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, technically difficult imaging and cardiotoxicity in oncology patients. It provides application of artificial intelligence to echocardiography. Its flagship product, Ventripoint Medical System (VMS+), enhances echocardiography to deliver cMRI levels of accuracy for volumetric measurements and ejection fractions for all four chambers of the heart. It has developed a solution that transforms cardiac care through its 3D ECHO and MRI software. VMS products are powered by its proprietary Knowledge Based Reconstruction technology, which is the result of a decade of development and provides accurate volumetric cardiac measurements equivalent to MRI.


TSXV:VPT - Post by User

VentriPoint Diagnostics Ltd > PR
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(99)
•••
Comment by G1945Von Nov 26, 2024 10:13am
45 Views
Post# 36331030

RE:RE:RE:PR

RE:RE:RE:PR
GrahamB wrote:
G1945V wrote:
GrahamB wrote: A news release about a $20,000 debt repaid with shares, but no detail details or context on the MAYO or sales

Seems odd.


You continually preach to the choir on the same issues.

For once, tell us something we don't know.


G1945V


You mean no sales, costs exceeding revenue, and GE alliance hasnt happenned, China hasnt happenned, Sales arent happenning

Well we are similar G1945-you say the same thing on yoiur soapbox-sales are coming,.....


The difference is -mine are based on facts and reality-your are based on dreaming about the future

Good thing its a discussion boiard where people are free to discuss, and newbies can learn

Its all for education, not to invest in

Anyone that bought in the ;ast few years is down, down , down!


"Well we are similar G1945-you say the same thing on your soapbox-sales are coming,.."

When did I say that, Graham? I'll say it now. Sales are coming!

G1945V

<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities